Digital Product Manager

Location: Biberach, Germany
Job Type: Full-Time
Employer: Boehringer Ingelheim
As Digital Product Manager, you are accountable for setting the direction for Boehringer Ingelheim major digital initiatives and leading them to success. In addition, you are passionate for drug discovery, experienced in implementing disruptive ideas into an organization and take advantage of data-driven digital innovation.

Embedded in Boehringer Ingelheim's growing Global Computational Biology and Digital Sciences Unit you will have an impact on reinventing R&D, thereby actively contributing to the discovery of breakthrough therapies that ultimately will improve the quality of human life.

Tasks & responsibilities

  • In your new role, you take over responsibility for strategic digital initiatives in R&D.
  • As product owner, the establishment and the continuous evolvement of ambitious product visions will be an essential part of the day-to-day business.
  • You will develop and implement a strategy to continuously validate the product scope and vision to meet our strategic goals and users' needs.
  • Not only will you collaborate with the target user community to ensure continuous value added but also with cross-functional product teams focusing on the translation of the product vision and strategy into user stories for implementation.
  • By working closely with stakeholders you ensure the development and implementation of a communication strategy around the product to maximize penetration and impact into the organization.

Requirements

  • PhD in life sciences, bioinformatics, or a related field
  • Multiple years of experience in life sciences / pharma R&D, as well as expertise in project management, digital product development and team leading
  • Profound domain knowledge in drug discovery and development
  • Strategic thinking, a well-structured way of working, and a strong digital mindset in order to constantly push forward digital initiatives
  • Strong entrepreneurial mindset paired with the willingness to challenge current ways of working
  • Excellent communication skills across multiple disciplines and cultural backgrounds

Apply for this job

At Boehringer Ingelheim we develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, we focus on long-term performance. We believe that, if we have talented and ambitious people who are passionate about innovation, there is no limit to what we can achieve; after all, we started with just 28 people. Now, we are powered by 50,000 employees globally who nurture a diverse, collaborative and inclusive culture.

Post your job offer now to start hiring the best digital health talent! For further information, please contact us.

Most Popular Now

Clanwilliam Brings Epic Care to the UK

Care homes looking to digitise their administration and care procedures have a new option with the launch of Epic Care in the UK. Epic Care is a modular, scalable system developed...

AI Language Models Write Good Doctor…

Generative AI should be able to write usable doctor's letters and thus potentially speed up medical documentation, according to a study by the University Medical Center Freiburg. Around 93% of...

West Yorkshire and Harrogate Hospitals S…

Clinicians working at five of the six trusts in the West Yorkshire Association of Acute Trusts (WYAAT) can access test results from across their pathology network, following a summer roll-out...

ChatGPT Shows Human-Level Assessment of …

As artificial intelligence advances, its uses and capabilities in real-world applications continue to reach new heights that may even surpass human expertise. In the field of radiology, where a correct...

When Detecting Depression, the Eyes have…

It has been estimated that nearly 300 million people, or about 4% of the global population, are afflicted by some form of depression. But detecting it can be difficult, particularly...

When it comes to Emergency Care, ChatGPT…

If ChatGPT were cut loose in the Emergency Department, it might suggest unneeded x-rays and antibiotics for some patients and admit others who didn't require hospital treatment, a new study...

HWL 2024 Brings Together a Record Number…

1 - 2 October 2024, Luxembourg. The second edition of Healthcare Week Luxembourg on 1 and 2 October 2024, organised by the Federation of Luxembourg Hospitals (FHL), in partnership with the...

AI Drives Development of Cancer Fighting…

University of Houston researchers and their students are developing a new software technology, based on artificial intelligence, for advancing cell-based immunotherapy to treat cancer and other diseases. CellChorus...

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

Revolutionizing Cardiovascular Risk Asse…

A recent position paper in the Asia-Pacific Journal of Ophthalmology explores the transformative potential of artificial intelligence (AI) in ophthalmology. Led by Lama Al-Aswad, Professor of Ophthalmology and Irene Heinz...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Why the NHS Needs a Transparency Revolut…

Opinion Article by Dr Mark Ratnarajah, NHS paediatrician and UK Managing Director for C2-Ai. Wes Streeting wanted 'no stone left unturned' when he asked Lord Darzi to examine the current state...